[A rare and mortal infection agent in patients with hematological malignancies: Saprochaete capitata]

Lale Aydın Kaynar, Zübeyde Nur Özkurt1, Burcu Ülküden

  • 1Gazi University Faculty of Medicine, Department of Hematology, Ankara, Turkey. zubeydenurozkurt@yahoo.com.

Mikrobiyoloji Bulteni
|January 27, 2017
PubMed

Insights

Saprochaete capitata is a rare fungal pathogen causing invasive infections in patients with hematologic malignancies. Early identification and aggressive treatment are crucial, as this infection carries a high mortality risk, especially in neutropenic patients.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Hematology

Background:

  • Saprochaete capitata (formerly Geotrichum capitatum) is a rare fungal agent causing invasive infections.
  • It can colonize skin, lungs, and intestines, leading to opportunistic infections, particularly in immunosuppressed individuals.
  • Invasive S. capitata infections have been reported in patients with hematological malignancies, often with a fatal outcome.

Observation:

  • Two cases of invasive S. capitata infection in acute leukemia patients with persistent neutropenic fever are presented.
  • Both patients received empirical caspofungin without response to broad-spectrum antibacterial therapy.
  • S. capitata was isolated from blood and catheter cultures in both cases.

Findings:

  • Despite antifungal treatment (amphotericin B, voriconazole) and interventions like stem cell transplantation, both patients experienced fatal outcomes.
  • Minimal inhibitory concentrations (MICs) indicated susceptibility to amphotericin B, voriconazole, and itraconazole, but resistance to fluconazole.
  • Virulence was confirmed in Galleria mellonella larvae model, showing rapid mortality post-infection.

Implications:

  • S. capitata poses a high mortality risk in neutropenic patients with hematological malignancies.
  • Persistent fever during caspofungin treatment in this patient population warrants consideration of S. capitata.
  • Aggressive and timely management strategies are essential for improving outcomes in invasive S. capitata infections.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.5K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.1K